CA1030469A - Antibiotics s7481/f-1 and f-2 from cylindrocarpon or tolypocladium - Google Patents

Antibiotics s7481/f-1 and f-2 from cylindrocarpon or tolypocladium

Info

Publication number
CA1030469A
CA1030469A CA215,287A CA215287A CA1030469A CA 1030469 A CA1030469 A CA 1030469A CA 215287 A CA215287 A CA 215287A CA 1030469 A CA1030469 A CA 1030469A
Authority
CA
Canada
Prior art keywords
cylindrocarpon
tolypocladium
antibiotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA215,287A
Other languages
French (fr)
Other versions
CA215287S (en
Inventor
Artur Ruegger
Eugen Harri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25713544&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA1030469(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CH1711173A external-priority patent/CH589716A5/en
Priority claimed from CH1404374A external-priority patent/CH603790A5/en
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of CA1030469A publication Critical patent/CA1030469A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K4/00Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/06Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from fungi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/885Trichoderma

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
CA215,287A 1973-12-06 1974-12-05 Antibiotics s7481/f-1 and f-2 from cylindrocarpon or tolypocladium Expired CA1030469A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1711173A CH589716A5 (en) 1973-12-06 1973-12-06 Antibiotics S 7481-F-1 and 2 - prepd. from new strains of Cylindrocarbon or Trichoderma esp. useful as immunosuppressant
CH1404374A CH603790A5 (en) 1974-10-21 1974-10-21 Antibiotics S 7481-F-1 and 2

Publications (1)

Publication Number Publication Date
CA1030469A true CA1030469A (en) 1978-05-02

Family

ID=25713544

Family Applications (1)

Application Number Title Priority Date Filing Date
CA215,287A Expired CA1030469A (en) 1973-12-06 1974-12-05 Antibiotics s7481/f-1 and f-2 from cylindrocarpon or tolypocladium

Country Status (19)

Country Link
JP (1) JPS5615235B2 (en)
AU (1) AU500889B2 (en)
CA (1) CA1030469A (en)
DD (1) DD115695A5 (en)
DE (2) DE2455859C2 (en)
DK (1) DK136780B (en)
ES (1) ES432559A1 (en)
FI (2) FI52851C (en)
FR (1) FR2253531B1 (en)
GB (1) GB1491509A (en)
HK (1) HK53880A (en)
IE (1) IE40549B1 (en)
IL (1) IL46180A (en)
MY (1) MY8100203A (en)
NL (1) NL179220C (en)
NO (1) NO744292L (en)
NZ (1) NZ176117A (en)
PH (1) PH13773A (en)
SE (1) SE423720B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102164944A (en) * 2008-07-29 2011-08-24 桑多斯股份公司 Method for processing microbiologically produced cyclic oligopeptides

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (en) 1975-11-04 1979-12-28 Sandoz Ag
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
DE2907460A1 (en) * 1978-03-07 1979-09-13 Sandoz Ag NEW RESORBABLE GALENIC COMPOSITIONS
SE448386B (en) * 1978-10-18 1987-02-16 Sandoz Ag NEW CYCLOSPORIN DERIVATIVES, PROCEDURE FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
EP0098457B1 (en) * 1980-02-14 1987-08-05 Sandoz Ag (1s,2r,3r)- and (1r,2s,3s)-nitrilo-1-carbonyl-3-methyl-2-oxy-heptanes and -hept-5-enes useful in the total synthesis of cyclosporins and processes for their production
US4396542A (en) 1980-02-14 1983-08-02 Sandoz Ltd. Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
EP0056782B1 (en) 1981-01-09 1984-08-01 Sandoz Ag Novel cyclosporins
JPS59129920U (en) * 1983-02-16 1984-08-31 日立造船株式会社 Opening/closing device for bypass valve with gate
GB8717300D0 (en) * 1987-07-22 1987-08-26 Nat Res Dev Cyclosporins
ES2095926T5 (en) 1990-11-02 2001-02-16 Novartis Ag CYCLOSPORINS
DE69222150T2 (en) * 1991-01-25 1998-01-15 Fujisawa Pharmaceutical Co PROCESS FOR THE PRODUCTION OF CYCLOSPORIN-A AND / OR C
KR100304324B1 (en) * 1994-10-13 2001-11-22 김용규 Method for manufacturing cyclosporine a
HUT77283A (en) 1994-11-03 1998-03-30 Novartis Ag. Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them
US6423233B1 (en) 2000-08-15 2002-07-23 Biogal Gyogyszergyar Rt. Purification process
CA2518265A1 (en) 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
US7511013B2 (en) 2004-09-29 2009-03-31 Amr Technology, Inc. Cyclosporin analogues and their pharmaceutical uses
US7378391B2 (en) 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
US7361636B2 (en) 2004-10-06 2008-04-22 Amr Technology, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102164944A (en) * 2008-07-29 2011-08-24 桑多斯股份公司 Method for processing microbiologically produced cyclic oligopeptides

Also Published As

Publication number Publication date
MY8100203A (en) 1981-12-31
NZ176117A (en) 1981-05-01
NL179220B (en) 1986-03-03
DE2455859A1 (en) 1975-06-12
DK136780C (en) 1978-05-01
DE2463138C2 (en) 1984-07-05
FR2253531A1 (en) 1975-07-04
NO744292L (en) 1975-06-30
IL46180A (en) 1978-07-31
DK617074A (en) 1975-07-28
ES432559A1 (en) 1977-03-01
NL179220C (en) 1986-08-01
FI343474A (en) 1975-06-07
JPS5615235B2 (en) 1981-04-09
DE2455859C2 (en) 1983-12-15
IE40549B1 (en) 1979-06-20
FI52851B (en) 1977-08-31
FI54606C (en) 1979-01-10
FI52851C (en) 1977-12-12
NL7415682A (en) 1975-06-10
AU500889B2 (en) 1979-06-07
IL46180A0 (en) 1975-03-13
IE40549L (en) 1975-06-06
HK53880A (en) 1980-10-03
JPS5089598A (en) 1975-07-18
FI771201A (en) 1977-04-15
GB1491509A (en) 1977-11-09
AU7608174A (en) 1976-06-10
DK136780B (en) 1977-11-21
PH13773A (en) 1980-09-23
SE423720B (en) 1982-05-24
FR2253531B1 (en) 1978-07-21
SE7415027L (en) 1975-06-09
FI54606B (en) 1978-09-29
DD115695A5 (en) 1975-10-12

Similar Documents

Publication Publication Date Title
CA1030469A (en) Antibiotics s7481/f-1 and f-2 from cylindrocarpon or tolypocladium
AU498757B2 (en) Cyclization of peptides
CA1005815A (en) Nonapeptide amide derivatives
AU508075B2 (en) Antibiotics from Aspergillus Rugulosus
CA1012567A (en) Excavating and loading system
CA1028949A (en) Contraceptive and antivenereal agents
CA999858A (en) 3-acylhydrazonomethyl rifamycins
CA1023676A (en) Purpuromycin antibiotics from actinoplanes lanthinogenes
CA998999A (en) 3-hydrazonomethyl rifamycins
CA1032097A (en) Antibiotics platomycin a and b from streptosporangium violaceochromogenes
CA929160A (en) Carboxylated dibenzoxazepines and dibenzothiazepines and processes thereof
AU502104B2 (en) Heterocyclic peptides
CA798042A (en) Self-leveling self-alining brick and block
AU499237B2 (en) Aminomethyl-methoxy-penams and cephems
CA975314A (en) Antibiotic polypeptide from bacillus polymyxa
CA975694A (en) Antibiotic polypeptide from bacillus polymyxa
CA873876A (en) Substituted benzoxazepines and benzothiazepines
AU481143B2 (en) Excavating and loading system
CA961061A (en) Workpiece-gripping reach and turnover attachment
CA910744A (en) Piston and piston ring combination
CA912380A (en) Piston and ring construction
CA898838A (en) Aluminous cement
AU8503075A (en) Antibiotics
AU484357B2 (en) Oxathiolanes and oxathianes
AU435223B2 (en) New cyclopeptides